Dr Monique Andersson
I completed my medical training in London (Charing Cross and Westminster Medical School), and specialist training in virology in both Bristol and London. My interest in HIV and hepatitis B led me back to my home country, South Africa, where I spent five years working at the University of Stellenbosch. I am currently a Consultant at the Oxford University Hospitals NHS Foundation Trust, and I continue to pursue my research interests in infectious diseases. I serve as a member of the World Health Organization (WHO) Global Validation Advisory Committee for the elimination of mother-to-child transmission of hepatitis B virus, HIV, and syphilis. Additionally, I am a member of the Joint Committee on Vaccination and Immunisation (JCVI) Influenza Sub-Committee, and the Hepatitis B Technical Working Group of the South African National Advisory Group on Immunisation.
My research is primarily focussed on strategies to control the transmission of hepatitis B, HIV and other sexually transmitted infections, particularly amongst pregnant women. In collaboration with colleagues from the Institute of Biomedical Engineering at the University of Oxford, we are developing point-of-care molecular diagnostic platforms, intended for deployment in resource-limited settings. Our clinical studies also include the application of Raman spectroscopy for the rapid diagnosis of infections.
More recently, I have developed an interest in occult hepatitis B infection (OBI). Employing single-cell and spatial transcriptomic technologies, we aim to elucidate the interactions between host genetics, immune responses, and HBV virology in individuals with chronic HBV infection compared to those with OBI. A more comprehensive understanding of these biological pathways may inform the identification of high-risk blood donors to prevent onward transmission and potential therapeutic targets for hepatitis B cure.
I am a Stipendiary Lecturer in Clinical Medicine at Merton College. I deliver bedside clinical teaching, employing patient-centred case discussions to develop students’ knowledge, clinical skills, and professionalism. I also teach postgraduate resident doctors and medical students on a range of infection-related topics. My principal areas of interest include infections during pregnancy, infections in immunocompromised individuals, and blood-borne viral infections.
Ahmadi Y, Yu Y, Cui Z, Huang WE, Andersson MI.Microb Biotechnol. 2025 Sep;18(9):e70214. doi: 10.1111/1751-7915.70214.PMID: 40879309
Ahmadi Y, Yu Y, Cui Z, Huang WE, Andersson MI. Microb Biotechnol. 2025 May;18(5):e70153. doi: 10.1111/1751-7915.70153.PMID: 40317856 Review.
Gonorrhoea: rising cases and antimicrobial resistance.
Davis P, Williams E, Andersson MI, Harrison OB, Hodgson SH.BMJ. 2025 May 20;389:r1001. doi: 10.1136/bmj.r1001.PMID: 40393737 No abstract available.
Downs LO, Okanda D, Chirro O, Zaharani M, Safari B, Aliyan N, Andersson MI, Tanaka Y, Etyang AO, Shimakawa Y, Githinji G, Matthews PC.Open Forum Infect Dis. 2025 Mar 6;12(3):ofaf125. doi: 10.1093/ofid/ofaf125. eCollection 2025 Mar.PMID: 40114975
Fu MX, Simmonds P, Andersson M, Harvala H.Rev Med Virol. 2024 Mar;34(2):e2525. doi: 10.1002/rmv.2525.PMID: 38375981 Review.
A new approach to prevent, diagnose, and treat hepatitis B in Africa.
Spearman CW, Andersson MI, Bright B, Davwar PM, Desalegn H, Guingane AN, Johannessen A, Kabagambe K, Lemoine M, Matthews PC, Ndow G, Riches N, Shimakawa Y, Sombié R, Stockdale AJ, Taljaard JJ, Vinikoor MJ, Wandeler G, Okeke E, Sonderup M; Hepatitis B in Africa Collaborative Network (HEPSANET).BMC Glob Public Health. 2023;1(1):24. doi: 10.1186/s44263-023-00026-1. Epub 2023 Nov 2.PMID: 38798823
Leston M, Ordóñez-Mena JM, Joy M, Hobbs FDR, de Lusignan S, Teh BW, de Groot I, McInnes I, El Sahly HM, Isaacs J, Andersson M, Raffi F, Lim WS, Conway R, Siebert S, Buchan I, Underwood M, Lowe D, Hoerger M, Griffiths CEM, Alunno A, Lee LYW; DESTINIES Consortium.EClinicalMedicine. 2025 May 5;83:103239. doi: 10.1016/j.eclinm.2025.103239. eCollection 2025 May.PMID: 40453534
